OTCMKTS:LTUS Lotus Pharmaceuticals (LTUS) Stock Forecast, Price & News $0.0055 0.00 (0.00%) (As of 10/4/2023 ET) Add Compare Share Share Today's Range$0.0055▼$0.005550-Day Range$0.0045▼$0.008052-Week Range$0.0040▼$0.0150VolumeN/AAverage Volume20,460 shsMarket Capitalization$14.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About Lotus Pharmaceuticals (OTCMKTS:LTUS) StockLotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.Read More LTUS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTUS Stock News HeadlinesSeptember 30, 2023 | msn.comLotus 78: The revolutionary car that changed Formula 1 foreverSeptember 19, 2023 | finance.yahoo.comETQ Adds Lotus Clinical Research to Roster of Life Sciences Firms Finding Success with ETQ Reliance Quality Management SystemOctober 4, 2023 | Legacy Research (Ad)Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”September 19, 2023 | msn.com‘You Do Not Need Glasses’: A Wellness Coach’s Bogus Claim — And Its 100-Year HistorySeptember 18, 2023 | msn.com‘You Do Not Need Glasses’: The 100-Year History Behind Wellness Coach’s Bogus ClaimSeptember 10, 2023 | msn.comLotus Eletre ‘Hyper SUV’ Spells End of the Brand as You Know ItSeptember 9, 2023 | msn.comLotus Just Unveiled Its First Electric ‘Hyper GT,’ the 905 HP EmeyaSeptember 8, 2023 | msn.comThe Lotus Emeya Is a 905-HP Electric Super SedanOctober 4, 2023 | Legacy Research (Ad)Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”September 7, 2023 | msn.comLotus Debuts “Lost” Type 66 Track Car For Limited Production, Costs $1.3MSeptember 7, 2023 | msn.comThe White Lotus season three has been hit by a major problemSeptember 2, 2023 | msn.comRelentless "Lotus" Takes Helm of Wagner: A New Leader EmergesAugust 30, 2023 | msn.comLotus Emeya 'hyper-GT' teased before September 7 debutAugust 30, 2023 | msn.comThe Lotus Emeya Will Be Its EV Super SedanAugust 30, 2023 | msn.comLotus Flower: Discover the Powerful Meaning, Symbolism, and Proper OccasionsAugust 30, 2023 | msn.comLotus Kind 66: long-lost racer revived with 830bhp V8August 29, 2023 | msn.comLotus Emeya Teaser Previews EV’s Active Aero Ahead Of September 7 DebutAugust 29, 2023 | msn.comThis Year Is Already a Success for LotusAugust 28, 2023 | msn.com2024 Lotus Type 66 First Look Review: Better Late Than NeverAugust 27, 2023 | msn.comThe White Lotus season 3 is in the works - here's everything we knowAugust 25, 2023 | msn.comLotus Found And Built A Lost 1970s Can-Am PrototypeAugust 24, 2023 | msn.comLotus Type 133 Electric Sedan: Everything We KnowAugust 24, 2023 | msn.comLotus Planning High-Performance Track-Only Type 133 DerivativeAugust 19, 2023 | yahoo.comWhite Lotus-ing? More Americans Are Opting for Luxury Villas Over 5-Star Hotels When Traveling AbroadAugust 17, 2023 | yahoo.comWhere Was ‘White Lotus’ Season 2 Filmed?August 11, 2023 | msn.comLotus Has Reportedly Already Taken 17,000 Orders This YearAugust 7, 2023 | msn.comLotus and KEF’s Limited Edition Speakers Produce Sound More Seductive than a Race TrackSee More Headlines Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address LTUS Company Calendar Today10/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:LTUS CUSIPN/A CIKN/A Webwww.lotuspharma.com Phone(941) 267-9684Fax86-10-6389-9867Employees233Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,694,510,000Free FloatN/AMarket Cap$14.82 million OptionableNot Optionable Beta0.34 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Zhong Yi Liu (Age 62)Founder, Chairman, Chief Exec. Officer and Pres Comp: $180kMs. Yan Zeng (Age 54)Chief Financial Officer and Principal Accounting Officer Dr. Xing Shen (Age 52)VP of Corp. Devel. Key CompetitorsVBI VaccinesNASDAQ:VBIVKazia TherapeuticsNASDAQ:KZIAOnconova TherapeuticsNASDAQ:ONTXGeoVax LabsNASDAQ:GOVXNanoViricidesNYSE:NNVCView All Competitors LTUS Stock - Frequently Asked Questions How have LTUS shares performed in 2023? Lotus Pharmaceuticals' stock was trading at $0.01 on January 1st, 2023. Since then, LTUS shares have decreased by 45.0% and is now trading at $0.0055. View the best growth stocks for 2023 here. What is Lotus Pharmaceuticals' stock symbol? Lotus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "LTUS." How do I buy shares of Lotus Pharmaceuticals? Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Lotus Pharmaceuticals' stock price today? One share of LTUS stock can currently be purchased for approximately $0.01. How much money does Lotus Pharmaceuticals make? Lotus Pharmaceuticals (OTCMKTS:LTUS) has a market capitalization of $14.82 million. How many employees does Lotus Pharmaceuticals have? The company employs 233 workers across the globe. How can I contact Lotus Pharmaceuticals? Lotus Pharmaceuticals' mailing address is 16 CHENG ZHUANG ROAD FENG TAI DISTRICT, BEIJING F4, 100071. The official website for the company is www.lotuspharma.com. The company can be reached via phone at (941) 267-9684 or via fax at 86-10-6389-9867. This page (OTCMKTS:LTUS) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.